Product Code: ETC067005 | Publication Date: Jun 2023 | Updated Date: Jan 2024 | Product Type: Report | |
Publisher: 6Wresearch | No. of Pages: 70 | No. of Figures: 35 | No. of Tables: 5 | |
The Malaysia non-oncology precision medicine market is expected to witness a CAGR of around 7.9% during the forecast period (2020-2025). The increasing prevalence of non-communicable diseases, such as diabetes and cardiovascular diseases in the country, is one of the major factors driving the growth of this market. Furthermore, rising government investments for healthcare infrastructure development are also fueling the growth of this market. Additionally, growing focus on personalized medicines and technological advancements have been contributing to its growth significantly in recent years
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Malaysia Non-Oncology Precision Medicine Market Overview |
3.1 Malaysia Country Macro Economic Indicators |
3.2 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, 2020 & 2027F |
3.3 Malaysia Non-Oncology Precision Medicine Market - Industry Life Cycle |
3.4 Malaysia Non-Oncology Precision Medicine Market - Porter's Five Forces |
3.5 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume Share, By Application, 2020 & 2027F |
3.6 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume Share, By Ecosystem, 2020 & 2027F |
4 Malaysia Non-Oncology Precision Medicine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Malaysia Non-Oncology Precision Medicine Market Trends |
6 Malaysia Non-Oncology Precision Medicine Market, By Types |
6.1 Malaysia Non-Oncology Precision Medicine Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Application, 2018 - 2027F |
6.1.3 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Neurology, 2018 - 2027F |
6.1.4 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Endocrinology, 2018 - 2027F |
6.1.5 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Life Sciences, 2018 - 2027F |
6.1.6 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Cardiovascular, 2018 - 2027F |
6.1.7 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Others, 2018 - 2027F |
6.2 Malaysia Non-Oncology Precision Medicine Market, By Ecosystem |
6.2.1 Overview and Analysis |
6.2.2 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Precision Diagnostics, 2018 - 2027F |
6.2.3 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Digital Health and Information Technology, 2018 - 2027F |
6.2.4 Malaysia Non-Oncology Precision Medicine Market Revenues & Volume, By Applied Sciences, 2018 - 2027F |
7 Malaysia Non-Oncology Precision Medicine Market Import-Export Trade Statistics |
7.1 Malaysia Non-Oncology Precision Medicine Market Export to Major Countries |
7.2 Malaysia Non-Oncology Precision Medicine Market Imports from Major Countries |
8 Malaysia Non-Oncology Precision Medicine Market Key Performance Indicators |
9 Malaysia Non-Oncology Precision Medicine Market - Opportunity Assessment |
9.1 Malaysia Non-Oncology Precision Medicine Market Opportunity Assessment, By Application, 2020 & 2027F |
9.2 Malaysia Non-Oncology Precision Medicine Market Opportunity Assessment, By Ecosystem, 2020 & 2027F |
10 Malaysia Non-Oncology Precision Medicine Market - Competitive Landscape |
10.1 Malaysia Non-Oncology Precision Medicine Market Revenue Share, By Companies, 2020 |
10.2 Malaysia Non-Oncology Precision Medicine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |